This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Brian Lee - Innovator in Cancer Treatment
Introduction
Brian Lee is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the combination of specific compounds to enhance therapeutic efficacy against hyperproliferative disorders.
Latest Patents
Brian Lee holds 1 patent for his invention titled "Combinations of AKT and MEK inhibitor compounds, and methods of use." This patent describes combinations that include a compound of formula I, or a pharmaceutically acceptable salt thereof, along with another agent selected from GDC-0973, PD-0325901, or a pharmaceutically acceptable salt thereof. The invention is particularly useful for treating hyperproliferative disorders, such as cancer.
Career Highlights
Brian Lee is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His role at Genentech allows him to collaborate with other talented professionals in the field, contributing to groundbreaking advancements in cancer therapies.
Collaborations
Some of Brian's coworkers include Deepak Sampath and Elizabeth Punnoose. Their collaborative efforts enhance the research environment and foster innovation within the company.
Conclusion
Brian Lee's contributions to cancer treatment through his patented inventions exemplify the impact of innovative research in the medical field. His work continues to pave the way for new therapeutic strategies against challenging diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile